1.

Eliminating viral hepatitis C in Belgium: the micro-elimination approach

2.

Eliminating viral hepatitis C in Belgium: the micro-elimination approach

3.

Eliminating viral hepatitis C in Belgium: the micro-elimination approach

4.

Eliminating viral hepatitis C in Belgium: the micro-elimination approach

5.

Eliminating viral hepatitis C in Belgium: the micro-elimination approach

6.

Eliminating viral hepatitis C in Belgium: the micro-elimination approach

7.

Eliminating viral hepatitis C in Belgium: the micro-elimination approach

8.

Eliminating viral hepatitis C in Belgium: the micro-elimination approach

9.

Eliminating viral hepatitis C in Belgium: the micro-elimination approach

1.

A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium

2.

A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium

3.

A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium

4.

A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium

1.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

2.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

3.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

4.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

5.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

6.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

7.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

8.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

9.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

1.

Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017

2.

Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017

3.

Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017

4.

Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017

5.

Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017

6.

Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017

7.

Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017

8.

Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017

9.

Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017

1.

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants

1.

Time trend of clinical cases of Lyme disease in two hospitals in Belgium, 2000–2013

2.

Time trend of clinical cases of Lyme disease in two hospitals in Belgium, 2000–2013

3.

Time trend of clinical cases of Lyme disease in two hospitals in Belgium, 2000–2013

4.

Time trend of clinical cases of Lyme disease in two hospitals in Belgium, 2000–2013

5.

Time trend of clinical cases of Lyme disease in two hospitals in Belgium, 2000–2013

6.

Time trend of clinical cases of Lyme disease in two hospitals in Belgium, 2000–2013

7.

Time trend of clinical cases of Lyme disease in two hospitals in Belgium, 2000–2013

8.

Time trend of clinical cases of Lyme disease in two hospitals in Belgium, 2000–2013

9.

Time trend of clinical cases of Lyme disease in two hospitals in Belgium, 2000–2013

1.

The impact of regular school closure on seasonal influenza epidemics: a data-driven spatial transmission model for Belgium

2.

The impact of regular school closure on seasonal influenza epidemics: a data-driven spatial transmission model for Belgium

3.

The impact of regular school closure on seasonal influenza epidemics: a data-driven spatial transmission model for Belgium

4.

The impact of regular school closure on seasonal influenza epidemics: a data-driven spatial transmission model for Belgium

1.

Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study

2.

Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study

3.

Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study

4.

Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study

1.

“With fever it’s the real flu I would say”: laypersons’ perception of common cold and influenza and their differences - a qualitative study in Austria, Belgium and Croatia

2.

“With fever it’s the real flu I would say”: laypersons’ perception of common cold and influenza and their differences - a qualitative study in Austria, Belgium and Croatia

3.

“With fever it’s the real flu I would say”: laypersons’ perception of common cold and influenza and their differences - a qualitative study in Austria, Belgium and Croatia

4.

“With fever it’s the real flu I would say”: laypersons’ perception of common cold and influenza and their differences - a qualitative study in Austria, Belgium and Croatia

5.

“With fever it’s the real flu I would say”: laypersons’ perception of common cold and influenza and their differences - a qualitative study in Austria, Belgium and Croatia

6.

“With fever it’s the real flu I would say”: laypersons’ perception of common cold and influenza and their differences - a qualitative study in Austria, Belgium and Croatia

7.

“With fever it’s the real flu I would say”: laypersons’ perception of common cold and influenza and their differences - a qualitative study in Austria, Belgium and Croatia

1.

Lymphogranuloma venereum is on the rise in Belgium among HIV negative men who have sex with men: surveillance data from 2011 until the end of June 2017

2.

Lymphogranuloma venereum is on the rise in Belgium among HIV negative men who have sex with men: surveillance data from 2011 until the end of June 2017

3.

Lymphogranuloma venereum is on the rise in Belgium among HIV negative men who have sex with men: surveillance data from 2011 until the end of June 2017

4.

Lymphogranuloma venereum is on the rise in Belgium among HIV negative men who have sex with men: surveillance data from 2011 until the end of June 2017